Baclofen/Samidorphan

巴氯芬/萨米多芬

Report date: 2024/06/25 11:04:15

Base Information

Drug NameBaclofen/Samidorphan
Drug Alias NameALKS-33/baclofen巴氯芬/SamidorphanBaclofen/ALKS-33Samidorphan/BaclofenBaclofen and Samidorphan +[7] 
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor antagonistsGamma-Aminobutyric Acid B Receptor agonists
TargetsMu opioid receptorGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BaclofenSamidorphan
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkermes Plc
Active IndicationsN/A
Inactive IndicationsAlcoholism

Other Information

ATC CodeN/A
Related LinksN/A